These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 6175495)
21. [Nonsurgical methods of treating prostatic adenoma]. Levin I; Lismer L; Sarvadio C; Simon D Ter Arkh; 1994; 66(1):78-80. PubMed ID: 7511839 [No Abstract] [Full Text] [Related]
22. Management of benign prostatic hyperplasia. Alternatives to standard therapy. Silverstein JI; Badlani GH; Smith AD Clin Geriatr Med; 1990 Feb; 6(1):69-84. PubMed ID: 1689206 [TBL] [Abstract][Full Text] [Related]
23. A comparative study of: long-term alpha-1-blocker, Doxazosin therapy versus surgery in the treatment of benign prostatic hyperplasia. Dutkiewicz S Mater Med Pol; 1995; 27(4):151-2. PubMed ID: 9000839 [TBL] [Abstract][Full Text] [Related]
24. [Tumorous prostatic diseases. I. Prostatic adenoma--genesis, clinical aspects, therapy]. Reichelt H Z Allgemeinmed; 1974 May; 50(15):688-93. PubMed ID: 4137484 [No Abstract] [Full Text] [Related]
25. Use of alpha-adrenergic inhibitors in treatment of benign prostatic hyperplasia and implications on sexual function. Kaplan SA Urology; 2004 Mar; 63(3):428-34. PubMed ID: 15028431 [No Abstract] [Full Text] [Related]
28. [Use of cernilton in the therapy of prostatic adenoma and chronic prostatitis]. Shaplygin LV; Sivakov AA Urologiia; 2007; (3):35-7, 39. PubMed ID: 17722618 [TBL] [Abstract][Full Text] [Related]
29. Single-blind, randomized controlled study of the clinical and urodynamic effects of an alpha-blocker (naftopidil) and phytotherapy (eviprostat) in the treatment of benign prostatic hyperplasia. Kaplan SA J Urol; 2005 Sep; 174(3):1011. PubMed ID: 16094031 [No Abstract] [Full Text] [Related]
32. Current role of alpha-blockers in the treatment of benign prostatic hyperplasia. Kaplan SA BJU Int; 2008 Nov; 102 Suppl 2():3-7. PubMed ID: 19032603 [No Abstract] [Full Text] [Related]
33. [Prostatic adenoma: new drugs, new surgical techniques]. Heinzl S Med Monatsschr Pharm; 1992 Dec; 15(12):362-4. PubMed ID: 1282201 [No Abstract] [Full Text] [Related]
34. [Expediency of switching from combined therapy with prostamol Uno and alpha-1-adrenoblockers to monotherapy with prostamol Uno in patients with prostatic adenoma]. Razumov SV; Egorov AA Urologiia; 2007; (3):47-50. PubMed ID: 17724829 [TBL] [Abstract][Full Text] [Related]
35. Medical treatments for benign prostatic hyperplasia and sexual function. Giuliano F BJU Int; 2008 Nov; 102 Suppl 2():8-12. PubMed ID: 19032604 [No Abstract] [Full Text] [Related]
36. Benign prostatic hyperplasia (BPH). Harv Mens Health Watch; 2006 Aug; 11(1):3. PubMed ID: 17111474 [No Abstract] [Full Text] [Related]
37. [Current drug therapy of benign prostatic hyperplasia]. Schmidbauer CP; Madersbacher S Wien Med Wochenschr; 1996; 146(8):161-4. PubMed ID: 8767400 [TBL] [Abstract][Full Text] [Related]
38. [Medical therapy of benign prostatic hyperplasia]. Altarac S Lijec Vjesn; 2005; 127(11-12):316-23. PubMed ID: 16583940 [TBL] [Abstract][Full Text] [Related]
39. [Therapy of benign prostatic hyperplasia with finasteride and doxazosin -- long-term studies support the combination]. Hausmann R; Thalmann G; Reich O; Steif CG Aktuelle Urol; 2004 Sep; 35(5):339-42. PubMed ID: 15383991 [No Abstract] [Full Text] [Related]